Development and Validation of a Stability-Indicating Reversed-Phase Liquid Chromatographic Method for the Simultaneous Determination of Methylprednisolone Aceponate and Benzyl Alcohol in Cream Formulation
Biomedical Chromatography, cilt.40, sa.5, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 40 Sayı: 5
- Basım Tarihi: 2026
- Doi Numarası: 10.1002/bmc.70429
- Dergi Adı: Biomedical Chromatography
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Chemical Abstracts Core, Chimica, Compendex, EMBASE, MEDLINE
- Anahtar Kelimeler: benzyl alcohol, core-shell column, high-performance liquid chromatography, methylprednisolone aceponate, stability-indicating methods
- İstanbul Üniversitesi Adresli: Evet
Özet
Methylprednisolone aceponate (MPA) is a nonhalogenated, diester corticosteroid, specifically designed to treat eczema. The amount of benzyl alcohol (BA), an excipient, is quite high in the cream formulation of MPA; therefore, the simultaneous determination of MPA, active ingredient, and BA is important. Chromatographic analysis was performed on an Agilent Poroshell 120 EC-C18 (100 × 2.1 mm 2.7 μm) column using acetonitrile–water (40:60, v/v) mixture as mobile phase with isocratic elution. The diode array detector (DAD) was set at 245 and 258 nm. The column was thermostated at 40°C ± 1°C. A flow rate of 0.5 mL/min was used to elute the analyte from the column. The calibration curve was linear in the concentration range 0.17–4.20 μg/mL for MPA and 1.50–35.0 μg/mL for BA. The R2 values for MPA and BA were found to be 0.9989 and 0.9999, respectively. The limit of detection was found to be 0.048 μg/mL for MPA, 0.46 μg/mL for BA, and the limit of quantification was found to be 0.17 μg/mL for MPA and 1.50 μg/mL for BA. MPA was exposed to stress conditions, and the stressed samples were analyzed using the proposed method, which can effectively separate MPA from its degradation products.